Clarivate to sell Life Sciences & Healthcare business
(7 Jul 2026) Clarivate has announced that it has entered into a definitive agreement to sell its Life Sciences & Healthcare (LS&H) business to healthcare-focused investment firm Altaris for $600 million. The transaction marks a significant strategic shift for Clarivate, leaving the company focused on its Academia & Government (A&G) and Intellectual Property (IP) businesses.…








